Tatjana Odrljin

Tatjana Odrljin serves as the Vice President of Clinical Research at Boston Pharmaceuticals since October 2019, having previously held the position of Executive Director of Clinical Development. Prior experience includes roles as Executive Director and Therapeutic Area Lead for Immune Mediated Inflammatory and Rare Disorders at Worldwide Clinical Trials, and Senior Medical Director at Takeda. Tatjana's career spans additional leadership positions, including Global Clinical Development Lead at Shire Pharmaceuticals and Medical Director for Metabolic Diseases at Alexion Pharmaceuticals. Notably, Tatjana contributed to significant clinical strategy development at Novartis Vaccines and Diagnostics as Medical Director and Cluster Physician, overseeing critical Meningitis trial programs and facilitating several regulatory submissions globally. Tatjana holds an MD from the University of Belgrade and a PhD in Physiopathology from the University of Kragujevac, Serbia.